Palmoplantar keratoderma-spastic paralysis syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2201OMIM:148360Q82.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Palmoplantar keratoderma-spastic paralysis syndrome is a very rare inherited condition that affects both the skin and the nervous system at the same time. It is sometimes called Charcot-Marie-Tooth disease with palmoplantar keratoderma, or referred to by the names of the doctors who first described it. The condition causes two main problems: thick, hardened skin on the palms of the hands and the soles of the feet (called palmoplantar keratoderma), and progressive muscle stiffness and weakness in the legs due to damage to the nerves that control movement (called spastic paralysis or spastic paraplegia). The skin changes usually appear in childhood and can cause discomfort, cracking, and difficulty with everyday tasks involving the hands and feet. The neurological symptoms, including leg stiffness, muscle weakness, and difficulty walking, tend to develop over time and can gradually worsen. Some people also experience changes in sensation, such as numbness or tingling in the limbs. There is currently no cure for this syndrome. Treatment focuses on managing symptoms. Skin care routines, moisturizers, and keratolytic creams can help soften the thickened skin. Physical therapy and mobility aids can help maintain walking ability and independence for as long as possible. A team of specialists is usually needed to provide the best care.

Also known as:

Key symptoms:

Thick, hardened skin on the palms of the handsThick, hardened skin on the soles of the feetLeg stiffness and muscle tightness (spasticity)Progressive weakness in the legsDifficulty walking or changes in the way a person walksNumbness or tingling in the hands or feetCracking or painful skin on the palms and solesReduced coordination or balance problemsMuscle cramps or spasms in the legs

Clinical phenotype terms (12)— hover any for plain English
Pain insensitivityHP:0007021Muscle flaccidityHP:0010547HemiplegiaHP:0002301
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Palmoplantar keratoderma-spastic paralysis syndrome.

View clinical trials →

No actively recruiting trials found for Palmoplantar keratoderma-spastic paralysis syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Palmoplantar keratoderma-spastic paralysis syndrome community →

No specialists are currently listed for Palmoplantar keratoderma-spastic paralysis syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Palmoplantar keratoderma-spastic paralysis syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Palmoplantar keratoderma-spastic paralysis syndromeForum →

No community posts yet. Be the first to share your experience with Palmoplantar keratoderma-spastic paralysis syndrome.

Start the conversation →

Latest news about Palmoplantar keratoderma-spastic paralysis syndrome

No recent news articles for Palmoplantar keratoderma-spastic paralysis syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What genetic tests should I have to confirm the diagnosis and identify the specific gene involved?,How quickly might my neurological symptoms progress, and what signs should I watch for?,What skin care products or treatments do you recommend for the thickened skin on my hands and feet?,What physical therapy program would be most helpful for maintaining my walking ability?,Are there any clinical trials or research studies I could participate in?,Should my family members be tested for this condition?,What mobility aids or home modifications should I consider now or plan for in the future?

Common questions about Palmoplantar keratoderma-spastic paralysis syndrome

What is Palmoplantar keratoderma-spastic paralysis syndrome?

Palmoplantar keratoderma-spastic paralysis syndrome is a very rare inherited condition that affects both the skin and the nervous system at the same time. It is sometimes called Charcot-Marie-Tooth disease with palmoplantar keratoderma, or referred to by the names of the doctors who first described it. The condition causes two main problems: thick, hardened skin on the palms of the hands and the soles of the feet (called palmoplantar keratoderma), and progressive muscle stiffness and weakness in the legs due to damage to the nerves that control movement (called spastic paralysis or spastic par

How is Palmoplantar keratoderma-spastic paralysis syndrome inherited?

Palmoplantar keratoderma-spastic paralysis syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Palmoplantar keratoderma-spastic paralysis syndrome typically begin?

Typical onset of Palmoplantar keratoderma-spastic paralysis syndrome is childhood. Age of onset can vary across affected individuals.